Skip to Main Content

Paper Details

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Blood
1358
2013
111 genes, MDS, MDS-myeloproliferative neoplasms, Myelodysplastic syndromes, RNA, acute myeloid leukemia, cancer, cancer genome, chromatin, chronic hematological malignancies, chronic myelomonocytic leukemia, dysplasia, ineffective, leukemia, myelodysplastic syndromes, neoplasms, oncogenic mutations, patients

Datasets

Release 1.2